214 related articles for article (PubMed ID: 32598869)
1. Changes in epilepsy burden after onchocerciasis elimination in a hyperendemic focus of western Uganda: a comparison of two population-based, cross-sectional studies.
Gumisiriza N; Kaiser C; Asaba G; Onen H; Mubiru F; Kisembo D; Siewe Fodjo JN; Colebunders R
Lancet Infect Dis; 2020 Nov; 20(11):1315-1323. PubMed ID: 32598869
[TBL] [Abstract][Full Text] [Related]
2. Prevalence and incidence of nodding syndrome and other forms of epilepsy in onchocerciasis-endemic areas in northern Uganda after the implementation of onchocerciasis control measures.
Gumisiriza N; Mubiru F; Siewe Fodjo JN; Mbonye Kayitale M; Hotterbeekx A; Idro R; Makumbi I; Lakwo T; Opar B; Kaducu J; Wamala JF; Colebunders R
Infect Dis Poverty; 2020 Mar; 9(1):12. PubMed ID: 32114979
[TBL] [Abstract][Full Text] [Related]
3. Effect of onchocerciasis elimination measures on the incidence of epilepsy in Maridi, South Sudan: a 3-year longitudinal, prospective, population-based study.
Jada SR; Amaral LJ; Lakwo T; Carter JY; Rovarini J; Bol YY; Logora MY; Hadermann A; Hopkins A; Fodjo JNS; Colebunders R
Lancet Glob Health; 2023 Aug; 11(8):e1260-e1268. PubMed ID: 37474232
[TBL] [Abstract][Full Text] [Related]
4. The effect of bi-annual community-directed treatment with ivermectin on the incidence of epilepsy in onchocerciasis endemic villages in South Sudan: a study protocol.
Abd-Elfarag G; Logora MY; Carter JY; Ojok M; Songok J; Menon S; Wit F; Lako R; Colebunders R
Infect Dis Poverty; 2018 Nov; 7(1):112. PubMed ID: 30424817
[TBL] [Abstract][Full Text] [Related]
5. Nodding syndrome and epilepsy in onchocerciasis endemic regions: comparing preliminary observations from South Sudan and the Democratic Republic of the Congo with data from Uganda.
Colebunders R; Hendy A; Mokili JL; Wamala JF; Kaducu J; Kur L; Tepage F; Mandro M; Mucinya G; Mambandu G; Komba MY; Lumaliza JL; van Oijen M; Laudisoit A
BMC Res Notes; 2016 Mar; 9():182. PubMed ID: 27005304
[TBL] [Abstract][Full Text] [Related]
6. Epilepsy and retarded growth in a hyperendemic focus of onchocerciasis in rural western Uganda.
Ovuga E; Kipp W; Mungherera M; Kasoro S
East Afr Med J; 1992 Oct; 69(10):554-6. PubMed ID: 1473507
[TBL] [Abstract][Full Text] [Related]
7. Clinical presentations of onchocerciasis-associated epilepsy (OAE) in Cameroon.
Siewe JFN; Ngarka L; Tatah G; Mengnjo MK; Nfor LN; Chokote ES; Boullé C; Nkouonlack C; Dema F; Nkoro GA; Njamnshi WY; Tabah EN; Zoung-Kanyi Bissek AC; Colebunders R; Njamnshi AK
Epilepsy Behav; 2019 Jan; 90():70-78. PubMed ID: 30513438
[TBL] [Abstract][Full Text] [Related]
8. High prevalence of epilepsy in two rural onchocerciasis endemic villages in the Mahenge area, Tanzania, after 20 years of community directed treatment with ivermectin.
Mmbando BP; Suykerbuyk P; Mnacho M; Kakorozya A; Matuja W; Hendy A; Greter H; Makunde WH; Colebunders R
Infect Dis Poverty; 2018 Jun; 7(1):64. PubMed ID: 29921319
[TBL] [Abstract][Full Text] [Related]
9. The prevalence of epilepsy follows the distribution of onchocerciasis in a west Ugandan focus.
Kaiser C; Kipp W; Asaba G; Mugisa C; Kabagambe G; Rating D; Leichsenring M
Bull World Health Organ; 1996; 74(4):361-7. PubMed ID: 8823957
[TBL] [Abstract][Full Text] [Related]
10. Onchocerciasis-associated epilepsy in the Democratic Republic of Congo: Clinical description and relationship with microfilarial density.
Siewe Fodjo JN; Mandro M; Mukendi D; Tepage F; Menon S; Nakato S; Nyisi F; Abhafule G; Wonya'rossi D; Anyolito A; Lokonda R; Hotterbeekx A; Colebunders R
PLoS Negl Trop Dis; 2019 Jul; 13(7):e0007300. PubMed ID: 31314757
[TBL] [Abstract][Full Text] [Related]
11. High prevalence of onchocerciasis-associated epilepsy in villages in Maridi County, Republic of South Sudan: A community-based survey.
Colebunders R; Y Carter J; Olore PC; Puok K; Bhattacharyya S; Menon S; Abd-Elfarag G; Ojok M; Ensoy-Musoro C; Lako R; Logora MY
Seizure; 2018 Dec; 63():93-101. PubMed ID: 30468964
[TBL] [Abstract][Full Text] [Related]
12. High prevalence of epilepsy in onchocerciasis endemic health areas in Democratic Republic of the Congo.
Lenaerts E; Mandro M; Mukendi D; Suykerbuyk P; Dolo H; Wonya'Rossi D; Ngave F; Ensoy-Musoro C; Laudisoit A; Hotterbeekx A; Colebunders R
Infect Dis Poverty; 2018 Aug; 7(1):68. PubMed ID: 30064504
[TBL] [Abstract][Full Text] [Related]
13. Onchocerciasis-Associated Epilepsy with Head Nodding Seizures-Nodding Syndrome: A Case Series of 15 Patients from Western Uganda, 1994.
Kaiser C; Asaba G; Rubaale T; Tukesiga E; Kipp W
Am J Trop Med Hyg; 2018 Nov; 99(5):1211-1218. PubMed ID: 30226148
[TBL] [Abstract][Full Text] [Related]
14. Low prevalence of epilepsy and onchocerciasis after more than 20 years of ivermectin treatment in the Imo River Basin in Nigeria.
Siewe JNF; Ukaga CN; Nwazor EO; Nwoke MO; Nwokeji MC; Onuoha BC; Nwanjor SO; Okeke J; Osahor K; Chimechefulam L; Ogomaka AI; Amaechi AA; Ezenwa CI; Ezike MN; Ikpeama C; Nwachukwu O; Eriama-Joseph AI; Nwoke BEB; Colebunders R
Infect Dis Poverty; 2019 Jan; 8(1):8. PubMed ID: 30670093
[TBL] [Abstract][Full Text] [Related]
15. Report of the first international workshop on onchocerciasis-associated epilepsy.
Colebunders R; Mandro M; Njamnshi AK; Boussinesq M; Hotterbeekx A; Kamgno J; O'Neill S; Hopkins A; Suykerbuyk P; Basáñez MG; Post RJ; Pedrique B; Preux PM; Stolk WA; Nutman TB; Idro R
Infect Dis Poverty; 2018 Mar; 7(1):23. PubMed ID: 29580280
[TBL] [Abstract][Full Text] [Related]
16. Epilepsy, retarded growth and onchocerciasis, in two areas of different endemicity of onchocerciasis in Burundi.
Newell ED; Vyungimana F; Bradley JE
Trans R Soc Trop Med Hyg; 1997; 91(5):525-7. PubMed ID: 9463656
[TBL] [Abstract][Full Text] [Related]
17. Epidemiology of onchocerciasis-associated epilepsy in the Mbam and Sanaga river valleys of Cameroon: impact of more than 13 years of ivermectin.
Siewe Fodjo JN; Tatah G; Tabah EN; Ngarka L; Nfor LN; Chokote SE; Mengnjo MK; Dema F; Sitouok AT; Nkoro G; Ntone FE; Bissek AZ; Chesnais CB; Boussinesq M; Colebunders R; Njamnshi AK
Infect Dis Poverty; 2018 Dec; 7(1):114. PubMed ID: 30501640
[TBL] [Abstract][Full Text] [Related]
18. Evolution of epilepsy prevalence and incidence in a Tanzanian area endemic for onchocerciasis and the potential impact of community-directed treatment with ivermectin: a cross-sectional study and comparison over 28 years.
Greter H; Mmbando B; Makunde W; Mnacho M; Matuja W; Kakorozya A; Suykerbuyk P; Colebunders R
BMJ Open; 2018 Mar; 8(3):e017188. PubMed ID: 29605818
[TBL] [Abstract][Full Text] [Related]
19. Mortality from epilepsy in an onchocerciasis-endemic area in West Uganda.
Kaiser C; Asaba G; Kasoro S; Rubaale T; Kabagambe G; Mbabazi M
Trans R Soc Trop Med Hyg; 2007 Jan; 101(1):48-55. PubMed ID: 16905166
[TBL] [Abstract][Full Text] [Related]
20. Impact of 19 years of mass drug administration with ivermectin on epilepsy burden in a hyperendemic onchocerciasis area in Cameroon.
Boullé C; Njamnshi AK; Dema F; Mengnjo MK; Siewe Fodjo JN; Bissek AZ; Suykerbuyk P; Lenou-Nanga CG; Nana-Djeunga HC; Kamgno J; Chesnais CB; Boussinesq M; Colebunders R
Parasit Vectors; 2019 Mar; 12(1):114. PubMed ID: 30890155
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
